SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-274925
Filing Date
2017-09-01
Accepted
2017-09-01 08:46:07
Documents
6
Period of Report
2017-10-13
Effectiveness Date
2017-09-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A d639604ddef14a.htm DEF 14A 553621
2 GRAPHIC g639604g09w53.jpg GRAPHIC 27465
3 GRAPHIC g639604g15o49.jpg GRAPHIC 36467
4 GRAPHIC g639604g45z11.jpg GRAPHIC 29513
5 GRAPHIC g639604pcb.jpg GRAPHIC 813
6 GRAPHIC g639604pcc.jpg GRAPHIC 773
  Complete submission text file 0001193125-17-274925.txt   686053
Mailing Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32587 | Film No.: 171064544
SIC: 2834 Pharmaceutical Preparations